Source:http://linkedlifedata.com/resource/pubmed/id/21149827
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2011-1-20
|
| pubmed:abstractText |
Elevation of C-reactive protein (CRP) in human blood accompanies inflammatory processes, including cardiovascular diseases. There is increasing evidence that the acute-phase reactant CRP is not only a passive marker protein for systemic inflammation but also affects the vascular system. Further, CRP is an independent risk factor for atherosclerosis and the development of hypertension. Another crucial player in atherosclerotic processes is the mineralocorticoid hormone aldosterone. Even in low physiological concentrations, it stimulates the expression and membrane insertion of the epithelial sodium channel, thereby increasing the mechanical stiffness of endothelial cells. This contributes to the progression of endothelial dysfunction. In the present study, the hypothesis was tested that the acute application of CRP (25 mg/L), in presence of aldosterone (0.5 nmol/L; 24 hour incubation), modifies the mechanical stiffness and permeability of the endothelium. We found that endothelial cells stiffen in response to CRP. In parallel, endothelial epithelial sodium channel is inserted into the plasma membrane, while, surprisingly, the endothelial permeability decreases. CRP actions are prevented either by the inhibition of the intracellular aldosterone receptors using spironolactone (5 nmol/L) or by the inactivation of epithelial sodium channel using specific blockers. In contrast, inhibition of the release of the vasodilating gas nitric oxide via blockade of the phosphoinositide 3-kinase/Akt pathway has no effect on the CRP-induced stiffening of endothelial cells. The data indicate that CRP enhances the effects of aldosterone on the mechanical properties of the endothelium. Thus, CRP could counteract any decrease in arterial blood pressure that accompanies severe acute inflammatory processes.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-(4-morpholinyl)-8-phenyl-4H-1-benz...,
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Amiloride,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Chromones,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Epithelial Sodium Channel,
http://linkedlifedata.com/resource/pubmed/chemical/Morpholines,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Azide,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/benzamil
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1524-4563
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
57
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
231-7
|
| pubmed:meshHeading |
pubmed-meshheading:21149827-Aldosterone,
pubmed-meshheading:21149827-Amiloride,
pubmed-meshheading:21149827-Animals,
pubmed-meshheading:21149827-Aorta,
pubmed-meshheading:21149827-C-Reactive Protein,
pubmed-meshheading:21149827-Cattle,
pubmed-meshheading:21149827-Cell Membrane Permeability,
pubmed-meshheading:21149827-Cells, Cultured,
pubmed-meshheading:21149827-Chromones,
pubmed-meshheading:21149827-Dose-Response Relationship, Drug,
pubmed-meshheading:21149827-Endothelial Cells,
pubmed-meshheading:21149827-Endothelium, Vascular,
pubmed-meshheading:21149827-Enzyme Inhibitors,
pubmed-meshheading:21149827-Epithelial Sodium Channel,
pubmed-meshheading:21149827-Fluorescent Antibody Technique,
pubmed-meshheading:21149827-Humans,
pubmed-meshheading:21149827-Mice,
pubmed-meshheading:21149827-Microscopy, Atomic Force,
pubmed-meshheading:21149827-Morpholines,
pubmed-meshheading:21149827-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:21149827-Sodium Azide,
pubmed-meshheading:21149827-Vasodilator Agents
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
C-reactive protein makes human endothelium stiff and tight.
|
| pubmed:affiliation |
Institute of Physiology II, Muenster, Germany. kusche@uni-muenster.de
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|